Results 171 to 180 of about 1,235,428 (322)

Supplementary Figure 1 from Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic Strategy

, 2023
Michael J. Campa, Elizabeth B. Gottlin, Ryan T. Bushey, Edward F. Patz   +3 more
openalex   +1 more source

Complement Factor H-Related 3 induces inflammation and complosome activation in human RPE cells [PDF]

, 2021
Nicole Schäfer, Anas J. Rasras, Delia Ceteras, Sabine Amslinger, Volker Enzmann, Herbert Jägle, Diana Pauly   +6 more
openalex   +1 more source

KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cells

FEBS Open Bio, EarlyView.
KLK7, a tissue kallikrein‐related peptidase, is elevated in advanced colorectal cancer and associated with shorter survival. High KLK7 levels in ascites correlate with peritoneal metastasis. In mice, KLK7 overexpression increases metastasis. In vitro, KLK7 enhances cancer cell proliferation, migration, adhesion, and spheroid formation, driving ...
Yosr Z. Haffani, Tobias Dreyer, Meriem Naim, Rea Lo Dico, Natalia A. Ignatenko, Viktor Magdolen, Dalila Darmoul   +6 more
wiley   +1 more source

Complement factor H attenuates TNF-α-induced inflammation by upregulating EIF3C in rheumatoid arthritis. [PDF]

J Transl Med, 2023
Jia Y, Feng B, Ji X, Tian X, Zhao L, Zhou J, Zhang W, Li M, Fei Y, Wu X.   +9 more
europepmc   +1 more source

Complement factor H (CFH) [PDF]

Science-Business eXchange, 2011
openaire   +1 more source

Mycobacterial cell division arrest and smooth‐to‐rough envelope transition using CRISPRi‐mediated genetic repression systems

FEBS Open Bio, EarlyView.
CRISPRI‐mediated gene silencing and phenotypic exploration in nontuberculous mycobacteria. In this Research Protocol, we describe approaches to control, monitor, and quantitatively assess CRISPRI‐mediated gene silencing in M. smegmatis and M. abscessus model organisms.
Vanessa Point, Wafaa Achache, Janïs Laudouze, Eliana Sepulveda Ramos, Mickaël Maziero, Céline Crauste, Stéphane Canaan, Pierre Santucci   +7 more
wiley   +1 more source

Complement Factor H Y403H Polymorphism in the Turkish Population

Balkan Journal of Medical Genetics, 2010
Yunus Arikan, Türker Bilgen, Ibrahim Keser   +2 more
doaj   +1 more source

Correction: Microbes Bind Complement Inhibitor Factor H a Common Site.

PLoS Pathogens, 2013
T. Meri, H. Amdahl, M. J. Lehtinen, S. Hyvärinen, J. V. McDowell, A. Bhattacharjee, S. Meri, R. Marconi, A. Goldman, T. S. Jokiranta   +9 more
doaj   +1 more source

Identification of complement factor H variants that predispose to pre-eclampsia: A genetic and functional study. [PDF]

BJOG, 2023
Lokki AI, Ren Z, Triebwasser M, Daly E, FINNPEC, Perola M, Auro K, Burwick R, Salmon JE, Daly M, Laivuori H, Atkinson JP, Java A, Meri S.   +13 more
europepmc   +1 more source

Pioglitazone plus (−)‐epigallocatechin gallate: a novel approach to enhance osteogenic performance in aged bone marrow mesenchymal stem cells

FEBS Open Bio, EarlyView.
Aged human bmMSCs are seeded in the scaffold. Osteoblastic induction can slightly increase cell's bone‐forming activity to produce bone‐like tissues, shown as the sporadic xylenol orange‐stained spots (the lower left image). Notably, pioglitazone plus EGCG co‐treatment dramatically increases cell's bone‐forming activity and bone‐like tissue production (
Ching‐Yun Chen, Jia‐Ci Jhang, Chun‐Yi Peng, Quốc Cường Nguyễn, Feng‐Huei Lin, Hung‐Ming Wu, Shankung Lin   +6 more
wiley   +1 more source